Zika Virus Vaccines Market 2027 By Type, Application, End User | The Insight Partners

Zika Virus Vaccines Market to 2027 - Global Analysis and Forecasts by Type (DNA- based vaccines, Inactivated Vaccines, Live-attenuated Vaccines, mRNA Vaccines, Genetically Engineered Vaccines); Application (Therapeutic Vaccines, Preventive Vaccines); End User (Hospitals, Clinics)

Report Code: TIPRE00004599 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Zika Virus Vaccine is charted for the prevention of symptoms and complications of Zika virus infections in humans. This virus is basically transmitted through Aedes mosquito bite which can also transmit chikungunya, dengue, and yellow fever. Other modes of transmission of this virus is through sex and from an infected mother to the fetus.

MARKET DYNAMICS
The Zika Virus Vaccines market is anticipated to grow in the forecast period owing to driving factors such as increasing incidence of Zika-infected individuals, increasing degree of preparedness in case of future outbreaks of Zika infections, growing awareness, and increasing human trials. Nevertheless, high cost required for R&D may restrict the growth of the market during the forecast period.

MARKET SCOPE
The "Global Zika Virus Vaccines Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Zika Virus Vaccines market with detailed market segmentation by Type, Application, End User and geography. The global Zika Virus Vaccines market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Zika Virus Vaccines market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Zika Virus Vaccines market is segmented on the basis of Type, Application and End User. Based on Type the market is segmented into DNA- based vaccines, Inactivated Vaccines, Live-attenuated Vaccines, mRNA Vaccines and Genetically Engineered Vaccines. Based on Application the market is segmented into Therapeutic Vaccines and Preventive Vaccines. Based on End User the market is segmented into Hospitals and Clinics.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Zika Virus Vaccines market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Zika Virus Vaccines market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Zika Virus Vaccines market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Zika Virus Vaccines market in these regions.

MARKET PLAYERS
The reports cover key developments in the Zika Virus Vaccines Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Zika Virus Vaccines Market are anticipated to lucrative growth opportunities in the future with the rising demand for Zika Virus Vaccines in the global market. Below mentioned is the list of few companies engaged in the Zika Virus Vaccines market.

The report also includes the profiles of key Zika Virus Vaccines market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Bharat Biotech International Ltd.
  • GeneOne Life Science Inc.
  • GlaxoSmithKline Plc.
  • Hawaii Biotech Inc.
  • Immunovaccine Inc.
  • Inovio Pharmaceuticals, Inc.
  • NewLink Genetics Co.
  • Sanofi S.A.
  • Takeda Pharmaceutical Co. Ltd.
  • Cerus Corporation
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Zika Virus Vaccines Market - By Type
1.3.2 Zika Virus Vaccines Market - By Application
1.3.3 Zika Virus Vaccines Market - By End User
1.3.4 Zika Virus Vaccines Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. ZIKA VIRUS VACCINES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ZIKA VIRUS VACCINES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ZIKA VIRUS VACCINES MARKET - GLOBAL MARKET ANALYSIS
6.1. ZIKA VIRUS VACCINES - GLOBAL MARKET OVERVIEW
6.2. ZIKA VIRUS VACCINES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ZIKA VIRUS VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. DNA- BASED VACCINES
7.3.1. Overview
7.3.2. DNA- based vaccines Market Forecast and Analysis
7.4. INACTIVATED VACCINES
7.4.1. Overview
7.4.2. Inactivated Vaccines Market Forecast and Analysis
7.5. LIVE-ATTENUATED VACCINES
7.5.1. Overview
7.5.2. Live-attenuated Vaccines Market Forecast and Analysis
7.6. MRNA VACCINES
7.6.1. Overview
7.6.2. mRNA Vaccines Market Forecast and Analysis
7.7. GENETICALLY ENGINEERED VACCINES
7.7.1. Overview
7.7.2. Genetically Engineered Vaccines Market Forecast and Analysis
8. ZIKA VIRUS VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. THERAPEUTIC VACCINES
8.3.1. Overview
8.3.2. Therapeutic Vaccines Market Forecast and Analysis
8.4. PREVENTIVE VACCINES
8.4.1. Overview
8.4.2. Preventive Vaccines Market Forecast and Analysis
9. ZIKA VIRUS VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. CLINICS
9.4.1. Overview
9.4.2. Clinics Market Forecast and Analysis
10. ZIKA VIRUS VACCINES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Zika Virus Vaccines Market Overview
10.1.2 North America Zika Virus Vaccines Market Forecasts and Analysis
10.1.3 North America Zika Virus Vaccines Market Forecasts and Analysis - By Type
10.1.4 North America Zika Virus Vaccines Market Forecasts and Analysis - By Application
10.1.5 North America Zika Virus Vaccines Market Forecasts and Analysis - By End User
10.1.6 North America Zika Virus Vaccines Market Forecasts and Analysis - By Countries
10.1.6.1 United States Zika Virus Vaccines Market
10.1.6.1.1 United States Zika Virus Vaccines Market by Type
10.1.6.1.2 United States Zika Virus Vaccines Market by Application
10.1.6.1.3 United States Zika Virus Vaccines Market by End User
10.1.6.2 Canada Zika Virus Vaccines Market
10.1.6.2.1 Canada Zika Virus Vaccines Market by Type
10.1.6.2.2 Canada Zika Virus Vaccines Market by Application
10.1.6.2.3 Canada Zika Virus Vaccines Market by End User
10.1.6.3 Mexico Zika Virus Vaccines Market
10.1.6.3.1 Mexico Zika Virus Vaccines Market by Type
10.1.6.3.2 Mexico Zika Virus Vaccines Market by Application
10.1.6.3.3 Mexico Zika Virus Vaccines Market by End User
10.1.6.4 US Zika Virus Vaccines Market
10.1.6.4.1 US Zika Virus Vaccines Market by Type
10.1.6.4.2 US Zika Virus Vaccines Market by Application
10.1.6.4.3 US Zika Virus Vaccines Market by End User
10.2. EUROPE
10.2.1 Europe Zika Virus Vaccines Market Overview
10.2.2 Europe Zika Virus Vaccines Market Forecasts and Analysis
10.2.3 Europe Zika Virus Vaccines Market Forecasts and Analysis - By Type
10.2.4 Europe Zika Virus Vaccines Market Forecasts and Analysis - By Application
10.2.5 Europe Zika Virus Vaccines Market Forecasts and Analysis - By End User
10.2.6 Europe Zika Virus Vaccines Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Zika Virus Vaccines Market
10.2.6.1.1 Germany Zika Virus Vaccines Market by Type
10.2.6.1.2 Germany Zika Virus Vaccines Market by Application
10.2.6.1.3 Germany Zika Virus Vaccines Market by End User
10.2.6.2 France Zika Virus Vaccines Market
10.2.6.2.1 France Zika Virus Vaccines Market by Type
10.2.6.2.2 France Zika Virus Vaccines Market by Application
10.2.6.2.3 France Zika Virus Vaccines Market by End User
10.2.6.3 Italy Zika Virus Vaccines Market
10.2.6.3.1 Italy Zika Virus Vaccines Market by Type
10.2.6.3.2 Italy Zika Virus Vaccines Market by Application
10.2.6.3.3 Italy Zika Virus Vaccines Market by End User
10.2.6.4 Spain Zika Virus Vaccines Market
10.2.6.4.1 Spain Zika Virus Vaccines Market by Type
10.2.6.4.2 Spain Zika Virus Vaccines Market by Application
10.2.6.4.3 Spain Zika Virus Vaccines Market by End User
10.2.6.5 United Kingdom Zika Virus Vaccines Market
10.2.6.5.1 United Kingdom Zika Virus Vaccines Market by Type
10.2.6.5.2 United Kingdom Zika Virus Vaccines Market by Application
10.2.6.5.3 United Kingdom Zika Virus Vaccines Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Zika Virus Vaccines Market Overview
10.3.2 Asia-Pacific Zika Virus Vaccines Market Forecasts and Analysis
10.3.3 Asia-Pacific Zika Virus Vaccines Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Zika Virus Vaccines Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Zika Virus Vaccines Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Zika Virus Vaccines Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Zika Virus Vaccines Market
10.3.6.1.1 Australia Zika Virus Vaccines Market by Type
10.3.6.1.2 Australia Zika Virus Vaccines Market by Application
10.3.6.1.3 Australia Zika Virus Vaccines Market by End User
10.3.6.2 China Zika Virus Vaccines Market
10.3.6.2.1 China Zika Virus Vaccines Market by Type
10.3.6.2.2 China Zika Virus Vaccines Market by Application
10.3.6.2.3 China Zika Virus Vaccines Market by End User
10.3.6.3 India Zika Virus Vaccines Market
10.3.6.3.1 India Zika Virus Vaccines Market by Type
10.3.6.3.2 India Zika Virus Vaccines Market by Application
10.3.6.3.3 India Zika Virus Vaccines Market by End User
10.3.6.4 Japan Zika Virus Vaccines Market
10.3.6.4.1 Japan Zika Virus Vaccines Market by Type
10.3.6.4.2 Japan Zika Virus Vaccines Market by Application
10.3.6.4.3 Japan Zika Virus Vaccines Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Zika Virus Vaccines Market Overview
10.4.2 Middle East and Africa Zika Virus Vaccines Market Forecasts and Analysis
10.4.3 Middle East and Africa Zika Virus Vaccines Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Zika Virus Vaccines Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Zika Virus Vaccines Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Zika Virus Vaccines Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Zika Virus Vaccines Market
10.4.6.1.1 South Africa Zika Virus Vaccines Market by Type
10.4.6.1.2 South Africa Zika Virus Vaccines Market by Application
10.4.6.1.3 South Africa Zika Virus Vaccines Market by End User
10.4.6.2 Saudi Arabia Zika Virus Vaccines Market
10.4.6.2.1 Saudi Arabia Zika Virus Vaccines Market by Type
10.4.6.2.2 Saudi Arabia Zika Virus Vaccines Market by Application
10.4.6.2.3 Saudi Arabia Zika Virus Vaccines Market by End User
10.4.6.3 U.A.E Zika Virus Vaccines Market
10.4.6.3.1 U.A.E Zika Virus Vaccines Market by Type
10.4.6.3.2 U.A.E Zika Virus Vaccines Market by Application
10.4.6.3.3 U.A.E Zika Virus Vaccines Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Zika Virus Vaccines Market Overview
10.5.2 South and Central America Zika Virus Vaccines Market Forecasts and Analysis
10.5.3 South and Central America Zika Virus Vaccines Market Forecasts and Analysis - By Type
10.5.4 South and Central America Zika Virus Vaccines Market Forecasts and Analysis - By Application
10.5.5 South and Central America Zika Virus Vaccines Market Forecasts and Analysis - By End User
10.5.6 South and Central America Zika Virus Vaccines Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Zika Virus Vaccines Market
10.5.6.1.1 Brazil Zika Virus Vaccines Market by Type
10.5.6.1.2 Brazil Zika Virus Vaccines Market by Application
10.5.6.1.3 Brazil Zika Virus Vaccines Market by End User
10.5.6.2 Argentina Zika Virus Vaccines Market
10.5.6.2.1 Argentina Zika Virus Vaccines Market by Type
10.5.6.2.2 Argentina Zika Virus Vaccines Market by Application
10.5.6.2.3 Argentina Zika Virus Vaccines Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ZIKA VIRUS VACCINES MARKET, KEY COMPANY PROFILES
12.1. BHARAT BIOTECH INTERNATIONAL LTD
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. GENEONE LIFE SCIENCE INC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GLAXOSMITHKLINE PLC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. HAWAII BIOTECH INC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. IMMUNOVACCINE INC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. INOVIO PHARMACEUTICALS, INC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NEWLINK GENETICS CO
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SANOFI S.A
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. TAKEDA PHARMACEUTICAL CO. LTD
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. CERUS CORPORATION
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

- Bharat Biotech International Ltd.
- GeneOne Life Science Inc.
- GlaxoSmithKline Plc.
- Hawaii Biotech Inc.
- Immunovaccine Inc.
- Inovio Pharmaceuticals, Inc.
- NewLink Genetics Co.
- Sanofi S. A.
- Takeda Pharmaceutical Co. Ltd.
- Cerus Corporation